The present invention provides a drug/a method for treating cancer arrived at by combining a compound represented by general formula (1), which has Axl inhibitory activity, and an EGFR tyrosine kinase inhibitor. The present invention provides an exceptional drug/a method for treating cancer having a powerful effect of suppressing resistance to EGFR tyrosine kinase inhibitor in cancer treatment, and having few side effects such as weight loss.
